| Takuma Richard Shito, DPT | |
|
341 Magnolia Ave, Suite 103, Corona, CA 92879-3330 | |
| (951) 256-2827 | |
| (951) 284-1666 |
| Full Name | Takuma Richard Shito |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 8 Years |
| Location | 341 Magnolia Ave, Corona, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699215087 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 292862 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Corona Orthopaedic Associates Medical Group Inc | 0547243586 | 12 |
News Archive
Three new studies by psychologists at the University at Buffalo have found that after receiving negative feedback about one's appearance, individuals who are highly sensitive to appearance-based rejection withdraw from social interactions and prefer to avoid even those with whom they have close relationships.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it has submitted an investigational new drug (IND) amendment to the United States Food and Drug Administration (FDA) which includes the design of a proposed Phase 3 clinical trial of Neoprobe's RIGScan® CR radiopharmaceutical.
More than £170,000 will be used to boost trauma and emergency nursing in Zambia to help the country cope with the strain on services caused by the COVID-19 pandemic.
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
› Verified 2 days ago
| Entity Name | Corona Orthopaedic Associates Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598872657 PECOS PAC ID: 0547243586 Enrollment ID: O20040610000656 |
News Archive
Three new studies by psychologists at the University at Buffalo have found that after receiving negative feedback about one's appearance, individuals who are highly sensitive to appearance-based rejection withdraw from social interactions and prefer to avoid even those with whom they have close relationships.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it has submitted an investigational new drug (IND) amendment to the United States Food and Drug Administration (FDA) which includes the design of a proposed Phase 3 clinical trial of Neoprobe's RIGScan® CR radiopharmaceutical.
More than £170,000 will be used to boost trauma and emergency nursing in Zambia to help the country cope with the strain on services caused by the COVID-19 pandemic.
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Takuma Richard Shito, DPT 341 Magnolia Ave, Suite 103, Corona, CA 92879-3330 Ph: (951) 256-2827 | Takuma Richard Shito, DPT 341 Magnolia Ave, Suite 103, Corona, CA 92879-3330 Ph: (951) 256-2827 |
News Archive
Three new studies by psychologists at the University at Buffalo have found that after receiving negative feedback about one's appearance, individuals who are highly sensitive to appearance-based rejection withdraw from social interactions and prefer to avoid even those with whom they have close relationships.
Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, announced today that it has submitted an investigational new drug (IND) amendment to the United States Food and Drug Administration (FDA) which includes the design of a proposed Phase 3 clinical trial of Neoprobe's RIGScan® CR radiopharmaceutical.
More than £170,000 will be used to boost trauma and emergency nursing in Zambia to help the country cope with the strain on services caused by the COVID-19 pandemic.
Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma.
› Verified 2 days ago
Kimberly Sneegas, P.T. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 20145 Kayne St, Corona, CA 92881 Phone: 951-818-4750 | |
Khuram A. Sial, M. D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1810 Fullerton Ave, Suite 104, Corona, CA 92881 Phone: 951-734-7246 Fax: 877-694-3331 | |
Jeremy Hector Reynoso, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 255 E Rincon St, Corona, CA 92879 Phone: 951-523-8509 Fax: 951-221-8475 |